TADALAFIL
- Product NDC
- 72189-145
- 11-digit product format
- 721890145
- Labeler code
- 72189
- Product ID
- 72189-145_397f5fde-810b-642f-e063-6294a90ae47b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TADALAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- direct rx
- Application
- ANDA209654
- Marketing category
- ANDA
- Marketing start
- 2020-11-12
- Substance
- TADALAFIL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TADALAFIL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TADALAFIL | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 742SXX0ICT |
| Rxcui | 403957 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-145-30 | TADALAFIL | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 72189-145-90 | TADALAFIL | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-145 | TADALAFIL TABLET [DIRECT RX] | 1 | Current NDC, Legacy NDC, 2 package rows | 20201113_b3ee8325-bcb2-43fd-e053-2a95a90a08c8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-145-30 | 72189014530 | 30 TABLET in 1 BOTTLE (72189-145-30) | 30 tablet | 2020-11-12 | 0000-00-00 | No | No | Current |
| 72189-145-90 | 72189014590 | 90 TABLET in 1 BOTTLE (72189-145-90) | 90 tablet | 2020-11-12 | | No | No | Current |